Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Strides Plans Injectables Re-entry As Mylan Non-Compete Nears End

Sun, 10/06/2019 - 10:34pm

Indian firm Strides to invest up to $40m in acquired Stelis for re-entry into generic injectables and multiple biosimilar APIs...

      Related Stories 

ILIAS Biologics CEO On Opening Pandora’s Box For Exosome Therapeutics

Fri, 10/04/2019 - 11:41am

Emerging Company Profile: South Korea-based ILIAS Biologics aims to establish an exosome therapeutic development pathway using its platform technology EXPLOR, which...

      Related Stories 

Venture Funding Deals: Late Summer Sees Slew Of Series B Mega-Rounds

Fri, 10/04/2019 - 11:35am

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a...

      Related Stories 

AstraZeneca Gains US OK For Fasenra In Patient-Friendly Form

Fri, 10/04/2019 - 6:51am

The company is keeping up the pressure on GSK, getting approval for self-administration for Fasenra a few months after a...

      Related Stories 

Eight Talking Points from ESMO

Fri, 10/04/2019 - 5:33am

Mehta Analysis: What Can Tesla Teach Pharma?

Fri, 10/04/2019 - 3:07am

The transformation of the automotive world has many lessons for biopharma, especially on the regulatory front, believes Viren Mehta of...

      Related Stories 

Promising Shionogi Candidate Moves Ahead In Gram-Negative Pneumonia

Thu, 10/03/2019 - 9:52pm

Novel Shionogi antibiotic candidate set to move ahead following positive results in Gram-negative pneumonia, where resistance and unmet needs remain...

      Related Stories 

New CEO At MorphoSys Seeking Partner For ‘CAR-T Killer’ Lymphoma Drug

Thu, 10/03/2019 - 7:19am

Analysts tip Munich-based company for greatness, but it will need a big pharma partner to take on Roche's Polivy in...

      Related Stories 

Executives On The Move: Regional And Global Position Changes At SIFI, EMD Serono And Acino

Thu, 10/03/2019 - 5:09am

EMD Serono welcomes SVP, North American medical affairs while ophthalmic products company SIFI SpA announces country manager, Italy and. At...

      Related Stories 

US Biosimilar Market – Who's In It For The Long Haul?

Wed, 10/02/2019 - 4:14pm

A biopharma conference in Mumbai hears how the US biosimilars landscape could potentially change over the long term when deep...

      Related Stories 

Asia Deal Watch: ASLAN, Bukwang Establish Immuno-Oncology JV In Singapore

Wed, 10/02/2019 - 12:28pm

The JV to be called JAGUAHR Therapeutics will focus on the AhR pathway. Simcere acquires Chinese rights to JW’s gout...

      Related Stories 

GSK's Trelegy On Track To Be First Triple Inhaled Regimen For Asthma

Wed, 10/02/2019 - 11:13am

The company filed an sNDA with the US FDA for the triple combination, hoping to expand its current COPD indication...

      Related Stories 

Pages